Related Experiment Video
Updated: Mar 1, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Kathryn C Fitzgerald1, Kassandra L Munger2, Hans-Peter Hartung3
1Department of Neurology and Neuroimmunology, Johns Hopkins School of Medicine, Baltimore, MA.
High salt intake does not appear to impact the progression or activity of multiple sclerosis (MS) in patients with clinically isolated syndrome (CIS). This study found no association between urinary sodium levels and MS conversion, disability, or MRI outcomes.
Area of Science:
- Neurology
- Immunology
- Dietary Science
Background:
- Dietary factors, including salt intake, are increasingly investigated for their role in autoimmune diseases.
- High salt consumption has been linked to various health issues, prompting research into its effects on neurological conditions like multiple sclerosis (MS).
- Understanding modifiable lifestyle factors is crucial for managing chronic conditions such as MS.
Purpose of the Study:
- To determine if a high-salt diet, indicated by urinary sodium concentration, accelerates the conversion from clinically isolated syndrome (CIS) to MS.
- To investigate the association between salt intake and MS disease activity, including clinical and magnetic resonance imaging (MRI) outcomes.
- To evaluate the impact of sodium excretion levels on disability progression, measured by the Expanded Disability Status Scale (EDSS).
Main Methods:
- The study analyzed data from the BENEFIT randomized clinical trial, involving 465 patients with CIS.
- Urinary sodium excretion was estimated using the Tanaka equations based on repeated spot urine samples collected over a 5-year follow-up period.
- Associations between cumulative average sodium levels and clinical outcomes (MS conversion, EDSS, relapse rate) and MRI outcomes (lesion volume, active lesions) were assessed.
Main Results:
- No significant association was found between average 24-hour urine sodium levels and conversion to clinically definite MS over the 5-year follow-up.
- Salt intake did not correlate with key clinical outcomes, including changes in EDSS or relapse rates.
- MRI-assessed MS activity, such as new active lesions and T2 lesion volume changes, also showed no significant link to estimated daily sodium intake.
Conclusions:
- This research, utilizing multiple urine sodium measurements and standardized follow-up, suggests that dietary salt intake does not influence the disease course or activity in patients with MS.
- The findings indicate that salt consumption is unlikely to be a significant factor in MS progression or exacerbation.
- Further research may explore other dietary components or lifestyle factors in MS management.
Related Concept Videos
Atherosclerosis III: Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

